Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$6.81
+4.37%
Mkt Cap $436.33M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+32.3%
Consensus $9.00 vs current $6.81
NASDAQ·Healthcare·Biotechnology
$6.81
+4.37%
Mkt Cap $436.33M
Buy
2
Hold
0
Sell
0
Price Target (6 analysts)
$9.00
Range $8.00 – $10.00
+32.3%
Consensus $9.00 vs current $6.81